Norliqva Solution
Product Images NDC 46287-035

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norliqva (NDC 46287-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cmp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Norliquid 01)

Chemical Structure (Norliquid 01)
Chemical structure of amlodipine, the active ingredient in NORLIQVA oral solution 1 mg/mL by CMP Pharma, Inc. The structure shows molecular bonds and chemical groups characteristic of amlodipine.*
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
A Kaplan-Meier event rate curve comparing Amlodipine and Placebo over 24 months. The y-axis represents event rate, and the x-axis shows time in months. The graph includes statistical information with a P-value of 0.003 and a hazard ratio of 0.691 (95% CI: 0.54, 0.88). The number of patients at risk at various time points is displayed below the x-axis.*
FDA Label Image

Figure 2 – Effects On Primary Endpoint Of Amlodipine Versus Placebo Across Sub-groups (Norliquid 03)

Figure 2 – Effects On Primary Endpoint Of Amlodipine Versus Placebo Across Sub-groups (Norliquid 03)
A forest plot chart illustrating hazard ratios with 95% confidence intervals for various patient subgroups comparing outcomes favoring amlodipine versus placebo. Subgroups include all patients, age groups (<65, >=65), gender, baseline sitting systolic blood pressure, baseline vessel disease and stenosis, and PCI-stent strata. The horizontal axis shows hazard ratio values from 0 to 2, with a reference line at 1.0.*
FDA Label Image

Principal Display Panel (150 mL Bottle Label)

Principal Display Panel (150 mL Bottle Label)
Label for Norliqva (amlodipine) Oral Solution 1 mg/mL, a 150 mL oral liquid prescription drug distributed by CMP Pharma, Inc. The label includes dosage strength, formulation, storage instructions, alcohol content, a note for pharmacists to dispense in original packaging, and the NDC 46287-035-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.